Difference between revisions of "The Future of Biotechnology for Medical Applications in 2015"
| Line 3: | Line 3: | ||
The Future of Biotechnology for medical application 2015<br><br> | The Future of Biotechnology for medical application 2015<br><br> | ||
==Research questions== | ==Research questions== | ||
Biotechnology seeks to treat or even cure: Cancer, AIDS, hemophilia, hepatitis, diabetes, growth failure, heart disease, dermatology and autoimmune disorders | |||
Over the last 20 years the biotech industry has grown from virtually none existing to a large industry with the two largest players having a market value around the 100 billion US dollar mark making them leading stocks on the Nasdaq exchange. <br> | |||
The strategic dilemma is where the industry is in the “industry life cycle”? Is the biotech industry going to keep showing a 30-50% growth rate per year in the next decennia or is the industry mature and will the growth be comparable with industries like CPG which grow rate is similar to parameters like the growth of the population, inflation or the GDP. Or, has the biotech industry reached its top and will the industry decline and perhaps disappear? <br> | |||
Revision as of 08:25, 19 September 2005
Introduction
This page will contain the results of the scenario planning process of group 4 of class RSM EMBA05 on the following subject:
The Future of Biotechnology for medical application 2015
Research questions
Biotechnology seeks to treat or even cure: Cancer, AIDS, hemophilia, hepatitis, diabetes, growth failure, heart disease, dermatology and autoimmune disorders
Over the last 20 years the biotech industry has grown from virtually none existing to a large industry with the two largest players having a market value around the 100 billion US dollar mark making them leading stocks on the Nasdaq exchange.
The strategic dilemma is where the industry is in the “industry life cycle”? Is the biotech industry going to keep showing a 30-50% growth rate per year in the next decennia or is the industry mature and will the growth be comparable with industries like CPG which grow rate is similar to parameters like the growth of the population, inflation or the GDP. Or, has the biotech industry reached its top and will the industry decline and perhaps disappear?